COMMUNIQUÉS West-GlobeNewswire

Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Join Startup Forum Panel at Databricks DATA + AI World Tour in Boston
10/09/2025
WARREN, N.J., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), today announced that Mittul Mehta, Chief Information Officer of Tevogen and Head of Tevogen.AI, will [...]
BioSig Technologies, Inc. Announces Corporate Rebrand to Streamex Corp.
10/09/2025
Strategic Rebranding to Focus on Expanded Business Model and Growth Strategy. New Ticker Symbol “STEX”. LOS ANGELES & VANCOUVER, British Columbia, Sept. 10, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ [...]
Idorsia shares new analyses of daridorexant for patients with insomnia at World Sleep 2025
10/09/2025
Allschwil, Switzerland – September 10, 2025 Idorsia Ltd (SIX: IDIA) shares new analyses of daridorexant for patients with insomnia and further characterizes insomnia disorder at World Sleep 2025, delivering on its [...]
Tecan announces change of leadership in the Partnering Business division
10/09/2025
Männedorf, Switzerland, September 10, 2025 – The Tecan Group (SIX Swiss Exchange: TECN) today announced a change of leadership in its Partnering Business division. Ralf Griebel, who has served as Head of the Partnering [...]
Marius Pharmaceuticals and Hims & Hers™ Collaborate to Expand Access to KYZATREX® (testosterone undecanoate) CIII Capsules, the First FDA-Approved Oral Testosterone Therapy Offered on the Hims & Hers Platform
10/09/2025
RALEIGH, N.C., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, Inc. today announced a collaboration with Hims & Hers™ , one of the largest digital health platforms for men, to make KYZATREX ® , an FDA- [...]
Partnership between Corewell Health and Nudj Health drives progress in chronic condition management
10/09/2025
The model is making lasting improvements to thousands of patients who have a broad spectrum of chronic conditions AUSTIN, Texas, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Corewell Health ™ patients who used virtual lifestyle [...]
Johns Hopkins Health Plans Opens 2026 Grant Application Period
10/09/2025
Baltimore-Washington Region Nonprofits Invited to Apply for Grants Up to $20,000 HANOVER, Md., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Johns Hopkins Health Plans has launched the grant application period for its 2026 [...]
Realize Medical and Canon USA Partner to Redefine Procedural Planning Through Spatial Computing with VR and Imaging Technology
10/09/2025
Collaboration aims to create the lab of the future, enabling safer, faster, and more precise interventions Key Benefits of Partnership Integration of VR and imaging: Combines Realize Medical’s VR platform with Canon’s [...]
Trethera Successfully Completes Enrollment of Phase 1 Dose Escalation Trial for Patients with Solid Tumors
10/09/2025
LOS ANGELES, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, announced today that [...]
Une plateforme néerlandaise rend les soins dermatologiques instantanément accessibles dans le monde entier
10/09/2025
Dermatology2Go se focalise sur les soins de la peau en ligne, sans temps d’attente et avec des informations fiables BERGEN OP ZOOM, Pays-Bas, 10 sept. 2025 (GLOBE NEWSWIRE) -- Une nouvelle plateforme néerlandaise a été [...]
NanoNewron Awarded $2.5 Million in NIH STTR Phase 2 Grant to Advance its Innovative NN-840 Alzheimer’s Disease Program
10/09/2025
The $2.5 Million in NIH STTR Phase 2 Grant allows NanoNewron to start the IND-enabling program for the NN-840 program with an IND submission expected next year This NIH grant award strongly confirms the scientific and [...]
KFSHRC Conducts 48% of Clinical Trials in Saudi Arabia During the First Half of 2025
10/09/2025
RIYADH, Saudi Arabia, Sept. 10, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) led Saudi healthcare institutions in clinical trials, conducting 48% of all clinical trials [...]
Saudi Food and Drug Authority, AAMI Partner on Medtech Best Practices
10/09/2025
SFDA and AAMI Sign Memorandum of Understanding Arlington, Virginia, Sept. 10, 2025 (GLOBE NEWSWIRE) -- The Association for the Advancement of Medical Instrumentation (AAMI) has signed a memorandum of understanding with [...]
neurocare group's Apollo TMS Therapy Devices Now Have FDA Clearance to Treat Adolescents Suffering With Major Depression
10/09/2025
Munich, Germany; Atlanta, Georgia - September 10, 2025 – neurocare group AG (“neurocare” or the “Company”), a leading innovator in personalized mental health and performance, today announced it has received FDA [...]
Eleos Launches Smarter Support for Group Therapy and SUD Care
10/09/2025
New Groups capability represents the first AI solution to deliver individual speaker summaries for group therapy sessions, enabling SUD organizations to achieve documentation compliance at scale Eleos to unveil product [...]
Wellcome Leap and Pivotal Commit $100 Million to Women’s Health Research to Deliver Breakthroughs in Years, Not Decades
10/09/2025
Partnership brings Leap’s total investment to a quarter billion dollars – advancing toward a $1 billion goal to transform outcomes for women worldwide SAN DIEGO, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Wellcome Leap, a U.S. [...]
Actuate Therapeutics Announces Pricing of $15.0 Million Public Offering of Common Stock
10/09/2025
CHICAGO and FORT WORTH, Texas, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for [...]
Artelo Biosciences Announces Publication of Preclinical Data Demonstrating Superior Efficacy and Bioavailability of ART12.11 in Reducing Stress-Induced Depression and Anxiety Symptoms
10/09/2025
SOLANA BEACH, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) , a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people [...]
Ernexa Therapeutics Provides Update on Operational Excellence and Performance
10/09/2025
The company’s operating loss declined by 51% year-over-year, reflecting a laser focus on relentless execution and significant progress in expense reduction CAMBRIDGE, Mass., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Ernexa [...]

Pages